alexan 50mg/ml
ebewe pharma gmbh nfg. kg - austria - cytarabinum - sol. inj. - 50mg/ml - antimetaboliti analogi ai bazelor pirimidinice
nevirapina sandoz 200 mg
pharmadox healthcare ltd. - malta - nevirapinum - compr. - 200mg - antivirale cu actiune directa inhibitori non-nucleozidici ai reverstranscriptazei
pneumolid 2 mg/ml
synthon bv - olanda - linezolidum - sol. perf. - 2mg/ml - alte antibacteriene alte antibacteriene
linezolid sandoz 2 mg/ml
sandoz gmbh - austria - linezolidum - sol. perf. - 2mg/ml - alte antibacteriene alte antibacteriene
dienille
laboratorios leon farma sa - spania - combinatii (dienogestum+etinilestradiolum) - compr. film. - contraceptive hormonale pentru uz sistemic progesteroni si estrogeni combinatii fixe
linezolid infomed 2 mg/ml
infomed fluids s.r.l. - romania - linezolidum - sol. perf. - 2mg/ml - alte antibacteriene alte antibacteriene
linezolid krka 2 mg/ml
krka, d.d., novo mesto - slovenia - linezolidum - sol. perf. - 2mg/ml - alte antibacteriene alte antibacteriene
nevirapina accord 400 mg
pharmadox healthcare ltd. - malta - nevirapinum - compr. elib. prel. - 400mg - antivirale cu actiune directa inhibitori non-nucleozidici ai reverstranscriptazei
lysakare
advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - leziuni radiații - detoxifying agents for antineoplastic treatment - lysakare este indicat pentru reducerea renală expunerea la radiații în timpul peptide receptor terapia cu radionuclizi (prrt) cu lutețiu (177lu) oxodotreotide la adulți.
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenți antineoplazici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.